ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CBX Cellular Goods Plc

0.375
0.00 (0.00%)
24 May 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Cellular Goods Plc LSE:CBX London Ordinary Share GB00BK964W87 ORD GBP0.001
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 0.375 0.35 0.40 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Catalog, Mail-order Houses 67k -3.31M -0.0055 -0.67 2.23M
Cellular Goods Plc is listed in the Catalog, Mail-order Houses sector of the London Stock Exchange with ticker CBX. The last closing price for Cellular Goods was 0.38p. Over the last year, Cellular Goods shares have traded in a share price range of 0.275p to 1.075p.

Cellular Goods currently has 602,250,000 shares in issue. The market capitalisation of Cellular Goods is £2.23 million. Cellular Goods has a price to earnings ratio (PE ratio) of -0.67.

Cellular Goods Share Discussion Threads

Showing 1401 to 1423 of 2050 messages
Chat Pages: Latest  58  57  56  55  54  53  52  51  50  49  48  47  Older
DateSubjectAuthorDiscuss
01/12/2021
11:55
Nice contributions and cracking statements on OCTP.

OCTP is so different to the crowded "CBD" revolution... where products are next to useless for pain control or eliminating some diseases.

As someone who understands first hand the relief cannabinoids can give to cancer sufferers, i cannot pray for the day quick enough that researchers like OCTP bring to market effective pain relief.

The listing today on the US market is not going to propel OCTP above 10p in one foul swoop, but as "Harbor Access" do their work then more and more of the millions of investors in the US become aware of OCTP so the price will rally..

I do not need to mention Moderna.

OCTP has the very real potential to become that once in many lifetimes 100 bagger.

For the time being I champion the dismissal of the old advisors and look forward to "Harbor Access" doing a great job in ensuring OCTP is provided the exposure it deserves.

10p by start of 2022

whites123
01/12/2021
11:08
Is he on Twitter ?Try Insta
oapknob1
01/12/2021
10:31
It's interesting that we didn't smash past 11p and fell back. Personally I am very surprised we are seeing any red here today. Very surprised.
samsung2020
01/12/2021
10:04
How long before the inevitable DB Tweet?
david gruen
01/12/2021
10:03
Probably a little bit of disappointment about the serum being out of stock until February but otherwise, we are off and running. The next step on the journey - I'm a holder
alloa2003
01/12/2021
09:16
Usual sell on news , it will recover later. Its game on now, so I'm in.
7rademark
01/12/2021
08:58
CBX is a great one..

I hold CBX, but I also hold OCTP and 2 RNS in the space of hours.

I did implore you guys to research OCTP.
From the pitiful rise it looks like majority of you did not.

Masses of opportunity still.

Its still 50% less than IPO price..

Last nights RNS was welcomed.
This mornings RNS was expected.
Both fantastic news.
Clear out of old advisors who having overseen the IPO listing have watched the shares fall to less than 50% of that IPO price.. Brilliant news.

A few weeks ago the appointment of North American advisors "Harbor Access"

A clear out of old dead wood (Non Exec Director)

New partnerships..

A rebound to well above 5p (8 to 9p) just to put it on even par with subsequent cannabinoid listings.

Except, OCTP has the attention of everyone because it deals with pain relief in those with awful diseases such as cancer....

The Americans will now be able to trade this stock and with Harbor Access doing the PR i foresee this rocketing in the next few months to an share price and MC of a company more worthy of a 10 bagger price.

whites123
01/12/2021
08:42
All about initial sales numbers and steady growth now
oapknob1
01/12/2021
08:41
Genie/Muppetmagician/KenDung/Skier1 coincidence eh.
oapknob1
01/12/2021
08:21
3p this week and that is being generous.
ken chung
01/12/2021
08:20
was expecting better than +0.80% rise
ak62
01/12/2021
08:08
20p plus by Friday
datait
01/12/2021
08:07
need sells to push this up.
datait
01/12/2021
08:05
Decent start, let's get to 14p today
samsung2020
01/12/2021
08:04
+50% TODAY
ak62
01/12/2021
07:28
1 December 2021

Cellular Goods PLC

("Cellular Goods" or "the Company")

Launch of inaugural product range and ecommerce platform

Cellular Goods (LSE: CBX), a UK-based provider of premium consumer products formulated with lab-made cannabinoids, is pleased to announce the launch today of its inaugural product ranges and ecommerce platform, found at cellulargoods.co.

The launch comprises two product ranges and comes just nine months after the start-up of the Company's commercial operations following its flotation on the London Stock Exchange.

The inaugural range comprises the UK's first premium CBG (cannabigerol) skincare offering including a serum, a face-oil and an after-shaving moisturiser. The products contain ultra-pure, biosynthetic CBG, which has demonstrated anti-inflammatory, anti-oxidant and anti-bacterial properties. All three products have been through an extensive testing process and are fully validated for marketing and labelling as suitable for sensitive skin, dermatologically tested and dermatologist approved.

The second range is a clinically validated CBD (cannabidiol) ingestibles range. This range complies with novel food regulations in both the UK and the EU and is certified under Good Manufacturing Practice (GMP) standards. The ingestibles range comprises a tincture, a spray and capsules, covering the most popular methods of consumption. These have been extensively tested to ensure safety, stability and quality. Both product ranges do not require the cultivation of the cannabis sativa plant, and contain 0% THC, the psychoactive component of cannabis sativa.

In addition, the Company's new ecommerce platform has gone live, enabling customers in the UK to place online purchase orders for five of the six products as of today. The skincare serum will go on sale from February 2022 due to supply constraints at the Company's manufacturing partner until early in the new year.

Alexis Abraham, Chief Executive of Cellular Goods, commented: "Today is a major milestone for the Company with the launch of the UK's first CBG skincare products on a best-in-class ecommerce platform. Leading with CBG sets us apart from the competition, and to also be able to offer consumers CBD ingestibles at the same time delivers on our vision to become the first true cannabinoid company. We have taken less than a year from a standing start to put Cellular Goods at the forefront of the cannabinoid and wellness industries, and as of today, we have started a new chapter in our growth by entering a revenue-generating phase. Consumers are now familiar with CBD, and we believe there is a substantial and growing demand for a more innovative and premium brand offering clean, green, and compliant products and look forward to delivering on our potential".

david gruen
01/12/2021
07:22
I got my £25 voucher for the online store. Mind you, zoroax is the only skin product I've ever used!
faz
01/12/2021
07:13
Alexis Abraham, Chief Executive of Cellular Goods, commented: "Today is a major milestone for the Company with the launch of the UK's first CBG skincare products on a best-in-class ecommerce platform. Leading with CBG sets us apart from the competition, and to also be able to offer consumers CBD ingestibles at the same time delivers on our vision to become the first true cannabinoid company. We have taken less than a year from a standing start to put Cellular Goods at the forefront of the cannabinoid and wellness industries, and as of today, we have started a new chapter in our growth by entering a revenue-generating phase. Consumers are now familiar with CBD, and we believe there is a substantial and growing demand for a more innovative and premium brand offering clean, green, and compliant products and look forward to delivering on our potential".
oapknob1
30/11/2021
21:44
Just checked. No wonder they changed their minds about a free sample. With the free 25 pounds discount, I would still have to spend another 25 pounds + postage for their cheapest product.Becks better get some of his pals to buy some and front a publicity campaign like he did with that whisky brand.
kickingking
30/11/2021
20:13
Products live on website.Looks good. Higher end of market
oapknob1
29/11/2021
13:13
n0rbie,

I would recommend researching OCTP if you have an interest in cannabinoids providing pain relief for diseases including cancer

Agreements with top scientific bodies.
Great shareholder base, means likely no requirement to need to go to market for funding.
OTC listing in the States very soon.
Less than 50% of IPO
Clear out of Directors and Non Exec to ensure full alignment and focus on future.

One could and should research any of the above.
The announcement of researching pain relief in Oncology (Cancer) is welcomed by millions the globe over.
Who doesnt know someone who has cancer and benefits from the pain relief THC provides?

The share price has been smashed because of the liquidity.
Today just small share purchases and the share price rockets.
Stick a Million or more shares away for the kids and the likelihood is in a few years time they will never have to work a day in their lives. 10 bagger is more likely to be replaced with 100 bagger if just one of the cannabinoids show to work, and we KNOW they work.. Cannabis works for pain.. we know it does, now we just need the scientific proof and its availability to all.

whites123
28/11/2021
19:31
Back when CBX launched on the market, the early investors were offered a free product sample when it was launched. Anyway received email stating that they will replace the free sample with a 25 pound voucher instead. It seems like the products are not going to be cheap.Hopefully plenty of product are sold and price goes back to 20p+
kickingking
28/11/2021
17:27
New IPO coming via Primary Bid:

N0rbie,

A company is listed already and making phenomenal progress with superb shareholder base, and less than 50% of IPO.

OCTP...... DYOR, expect fireworks when medical pain relief is provided to cancer victims and others who deal with chronic pain and diseases daily. The market they are targeting is £BILLIONS and they are well on their way with access to cannabinoid libraries.

whites123
Chat Pages: Latest  58  57  56  55  54  53  52  51  50  49  48  47  Older

Your Recent History

Delayed Upgrade Clock